Arcadia Biosciences Expands Nutrition Business Management Team, Adds Experienced Nutrition Executive
15 Oct 2010 --- For Arcadia, Karr will help build upon the company’s recent launch of SONOVA 400 high GLA Safflower Oil by guiding strategic investments to expand the product portfolio and strategic partnership base.
Oct 15 20100 --- Arcadia Biosciences, Inc., an agricultural technology company focused on developing technologies and products that benefit the environment and human health, announced that it has named James F. Karr to the position of director, strategic development. Karr will focus on the development and execution of strategic opportunities for Arcadia’s nutrition business.
Karr joins the company from GOJO Industries where he served as vice president, business development and innovation. Karr has also held health care and nutrition management positions with Kimberly-Clark, Monsanto Company, Henkel Nutrition, Sterling Health, and Bristol-Myers-Squibb. Within these roles, he has demonstrated his effectiveness in the identification of market needs and the application of innovative technologies to capitalize on them.
For Arcadia, Karr will help build upon the company’s recent launch of SONOVA 400 high GLA Safflower Oil by guiding strategic investments to expand the product portfolio and strategic partnership base.
“Significant opportunity exists to apply new technologies toward the development of products that can enhance human health. We’ve hit key milestones in our nutrition business and plan to intensify our investment in the area. The addition of Jim Karr will help speed the development of products people want and accelerate Arcadia’s growth in nutrition markets,” said Eric Rey, president and CEO of Arcadia. “Jim brings the kind of global, big company experience that can help us achieve the goals we’ve laid out for our nutrition business. He’s a proven leader with demonstrated success in building value around nutrition and health-related technologies.
To contact our editorial team please email us at editorial@cnsmedia.com
Subscribe now to receive the latest news directly into your inbox.
